LCTX
Lineage Cell Therapeutics Inc
0.971$
-5.7%
vs. previous close
Closing price · As of: Sep 28, 2026
Ownership
Ownership Structure
Who owns Lineage Cell Therapeutics Inc (LCTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.5% of the shares are freely tradable; institutional investors hold 51.7%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
51.7%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
4.9%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
75.5%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
19.0%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
253Mio.
Largest Shareholders
No ownership data is available for this stock yet.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.